Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Reportlinker Adds Gastric Cancer Drug Discoveries: what the future holds


      News provided by

      Reportlinker

      Apr 20, 2011, 05:57 ET

      Share this article

      Share this article


      NEW YORK, April 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

      Gastric Cancer Drug Discoveries: what the future holds

      http://www.reportlinker.com/p0483566/Gastric-Cancer-Drug-Discoveries what-the-future-holds .html

      Original analysis of the clinical potential and commercial prospects for companies, launched products and pipeline candidates put into current market context

      Original analysis of the clinical potential and commercial prospects for companies, launched products and pipeline candidates put into current market context.

      The market is set for rapid and significant growth

      There is room for considerable change in the gastric cancer market as improved therapies seek to improve patient outcomes for advanced disease. Over the next seven years, Espicom expects to see the market grow by 133% from US$846 million in 2010, to US$1.97 billion in 2017, with the targeted therapies accounting for most of this growth. While competition amongst these targeted therapies will intensify from 2013/4, Roche will continue to dominate this market with Herceptin, which was recently approved in Japan.

      Next generation chemotherapy

      While targeted therapies are expected to grow rapidly, it is chemotherapy agents which are leading the current market. One notable success of recent years is Roche's Xeloda, which is replacing 5-FU in the US and EU, where it has been approved as a first-line treatment in gastric cancer since March 2007. With US patents in force until 2013, Xeloda is the only branded chemotherapeutic for gastric cancer not facing generic competition at present.

      The rise of targeted therapies

      Espicom believes that by 2017, targeted therapies will account for over 60% of the gastric cancer market. Competition for Herceptin will initially come from GSK's Tykerb/Tyverb, but Roche's Avastin, Merck's Erbitux and Lilly's ramucirumab are just some of those waiting in the wings over the coming period. One of the most promising candidates is Bayer's Nexavar where very promising PII trial results have given optimism for its prospects.

      More Information...

      Critical Business Insights from this report which...

      Provides independent, reliable 7-year forecasts, market share and unique product scoring which give you real insights to the current and future business landscape

      Evaluates the competitive environment – assess winners and losers and know their pipeline content and status

      Covers major launched products and significant pipeline candidates

      Identifies promising mid-stage development candidates

      Forecasts the launch timeframe for new products or indications

      Summarises current clinical thinking on gastric cancer

      Contents

      List of Charts.v

      Executive Summary.1

      Market Analysis.2

      Current Market.2

      Next-Generation Chemotherapy.2

      Targeted Therapy3

      Future Market.4

      Sales Forecasts.7

      Competitive Analysis8

      Competitor Ratio Analysis10

      Research and Development12

      VEGF Pathway Inhibitors 13

      EGFr Inhibitors. 13

      Other Targeted Therapies of Interest 14

      Chemotherapy. 15

      Background Information16

      What is Gastric Cancer?.16

      The Stages of Gastric Cancer .16

      Survival Rates.17

      Risk Factors for Gastric Cancer.17

      Preventing Gastric Cancer18

      Current Treatments.18

      Surgery.18

      Chemotherapy.18

      Radiation Therapy.19

      Why are New Treatments Needed?19

      Patient Statistics.19

      Gastric Cancer Products.20

      Targeted Therapies .22

      Approved Products.22

      Herceptin22

      Phase III Products.31

      Afinitor31

      Avastin.38

      Erbitux.53

      Ramucirumab62

      Tykerb/Tyverb66

      Phase II Products74

      AMG 10274

      AMG 38676

      ARQ 197.79

      AUY92283

      GDC-044986

      Nexavar.89

      Nimotuzumab95

      Olaparib102

      Telatinib105

      Tremelimumab107

      Gastric Cancer Drug Discoveries

      TSU-68 109

      Vectibix111

      Phase I Products.118

      Axitinib118

      BMS-833923.118

      Brivanib.118

      CUDC-101118

      Recentin .118

      Vandetanib.118

      Chemotherapy119

      Approved Products.119

      Taxotere119

      Teysuno.132

      Xeloda. 136

      Phase II Products. 145

      Alimta. 145

      Ixempra 150

      Tesetaxel 154

      Appendix.157

      Phase Transition Probability. 157

      Source Material. 158

      List of Tables

      The Potential Launch Landscape for Gastric Cancer.4

      Gastric Cancer Sales Forecasts (2010-2017).7

      Competitor Ratio Analysis Scores.10

      Drugs in Clinical Development for Gastric Cancer 12

      TNM Stage Grouping16

      Five-year Gastric Cancer Survival Rates (US) 17

      Targeted Therapies for Gastric Cancer20

      Chemotherapy for Gastric Cancer.21

      Herceptin Sales by Company (2009-2017).30

      Herceptin Sales by Indication (2009-2017).30

      Afinitor Sales by Indication (2009-2017).37

      Avastin Sales by Company (2009-2017)50

      Avastin Sales by Indication (2009-2017).50

      Erbitux Sales by Company (2009-2017)60

      Erbitux Sales by Indication (2009-2017)61

      Ramucirumab Sales by Indication (2014-2017)65

      Tykerb/Tyverb Sales by Indication (2009-2017).72

      Studies in Metastatic CRC with EGFr-Targeting Monoclonal Antibodies in Irinotecan-Refractory Patients98

      Safety Profiles of Leading Anti-EGFr Products and Nimotuzumab99

      Efficacy of Docetaxel in the Treatment of NSCLC Patients Previously Treated with a Platinum-Based CT Regimen (Intent-to-Treat Analysis)

      Taxotere Sales by Indication (2009-2017)130

      S-1 Sales (2009-2017) 135

      Xeloda Sales by Company (2009-2017). 143

      Xeloda Sales by Indication (2009-2017). 143

      Probability of Launch. 157

      List of Charts

      Gastric Cancer Sales by Therapy (2010)2

      Market Share by Product (2010)4

      Market Share of Gastric Cancer Therapies (2010)5

      Market Share of Gastric Cancer Therapies (2017).5

      Market Share by Product (2017)6

      Major Players in Gastric Cancer by Market Share (2010).8

      Major Players in Gastric Cancer by Market Share (2017).9

      Competitor Ratio Analysis Scores. 11

      HER2 Signalling Pathway22

      Herceptin Sales (2009-2017)30

      Afinitor Mode of Action 31

      Afinitor Sales (2009-2017).37

      Avastin Mode of Action38

      Avastin Sales by Company (2009-2017)49

      Avastin Sales by Indication, 2010.52

      Avastin Sales by Indication, 2017.52

      Erbitux Sales (2009-2017)60

      Ramucirumab Sales (2014-2017)65

      Tykerb/Tyverb Total Sales (2009-2017)72

      Tykerb Sales by Indication, 201773

      AUY922 Mode of Action Within a Cancer Cell.83

      Nexavar's Dual Mode of Action89

      Schematic of EGFr Inhibition in Tumourigenesis.111

      TAX 317 Survival K_M Curves - Docetaxel 75mg/m2 vs Best Supportive Care 123

      TAX 320 Survival K_M Curves - Docetaxel 75mg/m2 vs Vinorelbine or Ifosfamide Control. 124

      Taxotere Sales (2009-2017) 129

      Taxotere Sales by Indication (2010).130

      Taxotere Sales by Indication (2017) 131

      S-1 Sales (2009-2017). 134

      Xeloda Sales (2009-2017) 142

      Xeloda Sales by Indication (2010) 143

      Xeloda Sales by Indication (2017)144

      To order this report:

      : Gastric Cancer Drug Discoveries: what the future holds

      More  Market Research Report

      Check our  Company Profile, SWOT and Revenue Analysis!

      CONTACT
      Nicolas Bombourg
      Reportlinker
      Email: [email protected]
      US: (805)652-2626
      Intl: +1 805-652-2626

      SOURCE Reportlinker

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.